ArticleFrontiers in pharmacology2021

Maprotiline Suppresses Cholesterol Biosynthesis and Hepatocellular Carcinoma Progression Through Direct Targeting of CRABP1.

Cancan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.